Osteoporosis, characterized by systemic impairment of bone mass and microarchitectural deterioration, represents a profound failure in the dynamic equilibrium of bone remodeling. This review synthesizes contemporary insights from biophysics and biochemistry to deconstruct the pathogenesis of osteoporosis into a hierarchical failure of molecular and cellular systems¹. We begin at the nanoscale, examining the altered compositional biochemistry of the bone matrix collagen cross-linking, non-collagenous protein signaling, and mineral crystal properties that fundamentally compromises material resilience.² We then ascend to the cellular scale, detailing the biochemical signaling cascades (RANKL/RANK/OPG, Wnt/β- catenin, sclerostin) that govern osteoclast and osteoblast activity, framing their dysregulation as a breakdown in communication networks³. Integrating these with biophysical principles, we explore how mechanosensing via osteocytic lacunocanalicular networks and integrin-mediated focal adhesions translates physical force into biochemical anabolic signals, and how this transduction is blunted in aging and disuse.4 The review emphasizes the concept of bone as a composite material, where osteoporosis-induced changes in mineral-to-collagen ratio, carbonate substitution, and collagen integrity degrade its inherent fracture resistance, quantified by parameters such as elastic modulus, toughness, and fatigue life.5 Finally, we discuss emerging diagnostic technologies leveraging these principles (e.g., Raman spectroscopy, nanoindentation) and novel therapeutic strategies targeting specific biochemical pathways (anti-sclerostin, cathepsin K inhibitors) and biophysical interventions (vibration therapy, electromagnetic field stimulation).6 This integrative perspective posits osteoporosis not merely as a quantitative loss of bone, but as a qualitative disintegration of a sophisticated biomaterial, guiding future research towards multi-scale, mechanism-based interventions.
Review Article
English
P. 27-33